FYERS
Norris Medicines19.67
+0.00 (+0.00%)

Norris Medicines Share Price

19.67+0.00 (+0.00%)
+18.21% past 1 Year

Corporate filings & documents

Announcements

Newspaper advertisement regarding the 35th Annual General Meeting of the Company.
2 weeks ago
Newspaper advertisement regarding the 35th Annual General Meeting of the Company.
2 weeks ago
Annual Report of the Company for the Financial year 2025-26.
2 weeks ago
Annual Report of the Company for the Financial year 2025-26.
2 weeks ago
Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26
2 weeks ago
Notice of 35th Annual General Meeting of the Company for the Financial Year 2025-26
2 weeks ago
Intimation of Book Closure for 35th AGM of the Company
2 weeks ago
Intimation of Book Closure for 35th AGM of the Company
2 weeks ago
Outcome of the Board Meeting on Thursday 03rd September 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015
3 weeks ago
Outcome of the Board Meeting on Thursday 03rd September 2026 pursuant to Regulation 30 of the SEBI(LODR) Regulations 2015
3 weeks ago
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September 2026 till August 31 2029 be liable to retire by rotation.
1 month ago
Appointment of Mr. Vimal Dhirendra Shah (DIN: 01506655) as a Managing Director (Promoter and Executive) of the Company for a term of 3 (Three) consecutive years effective from 1st September 2026 till August 31 2029 be liable to retire by rotation.
1 month ago
Financial Results for the Quarter ended June 30 2026
1 month ago
Financial Results for the Quarter ended June 30 2026
1 month ago
Board Meeting held on August 14 2026 for the quarter ended June 30 2026.
1 month ago
Board Meeting held on August 14 2026 for the quarter ended June 30 2026.
1 month ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
1 month ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results for the Quarter Ended 30th June 2026
1 month ago
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
1 month ago
Intimation relating to appointment of Mr. Iqubal Ismail Patel as Chief Financial Officer (CFO) & Key Managerial Personnel (KMP) of the Company in the meeting of the Board dated 30th July 2026.
1 month ago
Outcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
1 month ago
Outcome of Board Meeting held on Thursday July 30 2026 pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
1 month ago
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
2 months ago
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 30 June 2026.
2 months ago
Intimation for Closure of Trading Window
3 months ago
Intimation for Closure of Trading Window
3 months ago
Appointment of Internal Auditor w.e.f 30.05.2026
3 months ago
Appointment of Internal Auditor w.e.f 30.05.2026
3 months ago
As per attachment.
3 months ago
As per attachment.
3 months ago
As per attachment.
3 months ago
As per attachment.
3 months ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve As per attachment.
4 months ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve As per attachment.
4 months ago
As per attachment.
5 months ago
As per attachment.
5 months ago
As per attachment.
6 months ago
As per attachment.
6 months ago
As per attachment.
7 months ago
As per attachment.
7 months ago
As per attachment
7 months ago
As per attachment.
7 months ago
As per attachment.
7 months ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve As per attachment.
7 months ago
As per attachment.
7 months ago
As per attachment.
8 months ago
As per attachment.
9 months ago
Intimation regarding Order passed by Honble High Court in Criminal Appeal No. 89 of 2020.
9 months ago
As per attachment.
10 months ago
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve As per attachment
10 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Norris Medicines Ltd Share Price Today

The Norris Medicines Ltd share price today is ₹13.65. During the trading session, the Norris Medicines Ltd share price opened at ₹0.00 and recorded an intraday high of ₹0.00 and a low of ₹0.00. Last closing price was ₹13.65. Over the past 52 weeks, the Norris Medicines Ltd share price has ranged between ₹12.00 and ₹19.63. The current Norris Medicines Ltd stock price reflects real-time market activity based on executed trades on the exchange.